Table 2 ART regimens at time of baseline non-suppressed viral load
ART REGIMEN AT TIME OF VL NON-SUPPRESSION | Freq. | Percent | Cum. |
|---|---|---|---|
ABC-3TC-ATV/r | 1 | 0.31 | 0.31 |
ABC-3TC-EFV | 1 | 0.31 | 0.62 |
ABC-3TC-LPV/r | 2 | 0.62 | 1.24 |
AZT-3TC-ATV/r | 9 | 2.79 | 4.02 |
AZT-3TC-DTG | 1 | 0.31 | 4.33 |
AZT-3TC-EFV | 27 | 8.36 | 12.69 |
AZT-3TC-LPV/r | 4 | 1.24 | 13.93 |
AZT-3TC-NVP | 49 | 15.17 | 29.10 |
TDF-3TC-ATV/r | 26 | 8.05 | 37.15 |
TDF-3TC-DTG | 63 | 19.50 | 56.66 |
TDF-3TC-EFV | 115 | 35.60 | 92.26 |
TDF-3TC-LPV/r | 13 | 4.02 | 96.28 |
TDF-3TC-NVP | 12 | 3.72 | 100.00 |
Total | 323 | 100.00 | Â |